Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum

Annals of the New York Academy of Sciences

Volumn 997, Issue , 2003, Pages 136-149

  Mastorakos, George ^a,b   Ilias, Ioannis ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Corticotropin; Corticotropin releasing hormone; Female; Fetus; Human; Hypothalamo hypophyseal system; Pituitary adrenal system; Pregnancy; Puerperium

Indexed keywords

ARGIPRESSIN; BINDING PROTEIN; CORTICOSTEROID; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; FAS LIGAND; HYDROCORTISONE; PRASTERONE SULFATE;

CELLULAR DISTRIBUTION; CHILDBIRTH; CIRCADIAN RHYTHM; CONFERENCE PAPER; CUSHING SYNDROME; CYTOTROPHOBLAST; DECIDUALIZATION; ENDOMETRIUM; FETUS BLOOD; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HORMONAL REGULATION; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HYPERCORTISOLISM; HYPOPHYSIS FUNCTION; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; LABOR; LUTEAL CELL; LUTEOLYSIS; MATERNAL BLOOD; MYOMETRIUM; NONHUMAN; OVARY; OVULATION; PARACRINE SIGNALING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PUERPERIUM; RADIOIMMUNOASSAY; ANIMAL; COMPARATIVE STUDY; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DEVELOPMENT; PUERPERAL DISORDER; REVIEW; SECRETION; SENSITIVITY AND SPECIFICITY;

ANIMALIA; OVIS ARIES; PRIMATES;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; FETUS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MATERNAL-FETAL EXCHANGE; PITUITARY-ADRENAL SYSTEM; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY OUTCOME; PUERPERAL DISORDERS; SENSITIVITY AND SPECIFICITY;

EID: 0642303160     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1290.016     Document Type: Conference Paper

References (127)

1. CHROUSOS, G.P. et al., Eds. 1988. Mechanisms of physical and emotional stress. Advances in Experimental Medicine and Biology, Vol. 245. Plenum Press. New York.
2. CHROUSOS, G.P. et al. 1992. The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. JAMA 267: 1244-1252.
3. RIVIER, C. et al. 1982. In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, β-endorphin and corticosterone. Endocrinology 110: 272-278.
4. VALE, W. et al. 1983. Chemical and biological characterization of corticotropin releasing factor. Recent Prog. Horm. Res. 39: 245-270.
5. SWANSON, L.W. 1983. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36: 165-186.
6. GIRALDI, F.P. & F. CAVAGNINI. 1998. Corticotropin-releasing hormone is produced by rat corticotropes and modulates ACTH secretion in a paracrine/autocrine fashion. J. Clin. Invest. 101: 2478-2484.
7. SAWCHENKO, P.E., L.W. SWANSON & W.W. VALE. 1984. Corticotropin- releasing factors: coexpression within distinct subsets of oxytocin-, vasopressin-, and neurotensin-immunoreactive neurons in the hypothalamus of the male rat. J. Neurosci. 4: 1118-1129.
8. SCHURMEYER, T.H. et al. 1984. Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion. J. Clin. Endocrinol. Metab. 59: 1103-1108.
9. CHROUSOS, G.P. 1995. The hypothalamic-pituitary-adrenal axis and the immune/inflammatory reaction. N. Engl. J. Med. 332: 1351-1362.
10. MASTORAKOS, G. & I. ILIAS. 2000. Maternal hypothalamic-pituitary- adrenal axis in pregnancy and the postpartum period: postpartum-related disorders. Ann. N. Y. Acad. Sci. 900: 95-106.
11. MASTORAKOS, G. et al. 1994. Presence of immunoreactive corticotropin releasing hormone (CRH) in thyroid lesions. Am. J. Pathol. 145: 1159-1167.
12. MASTORAKOS, G. et al. 1995. Immune corticotropin-releasing hormone is present in the eyes of and promotes experimental autoimmune uveoretinitis in rodents. Endocrinology 136: 4650-4658.
13. THEOHARIDES, T.C. et al. 1998. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 139: 403-413.
14. GRINO, M., G.P. CHROUSOS & A.N. MARGIORIS. 1987. The corticotropin releasing hormone gene is expressed in human placenta. Biochem. Biophys. Res. Commun. 148: 1208-1214.
15. MASTORAKOS, G. et al. 1996. Presence of immunoreactive corticotropin-releasing hormone in human endometrium. J. Clin. Endocrinol. Metab. 81: 1046-1050.
16. FERRARI, A., F. PETRAGLIA & E. GURPIDE. 1995. Corticotropin releasing factor decidualizes human endometrial stromal cells in vitro. Interaction with progestin. J. Steroid Biochem. Mol. Biol. 54: 251-255.
17. PETRAGLIA, F. et al. 1992. Human decidua and in vitro decidualized endometrial stromal cells at term contain immunoreactive corticotropin-releasing factor (CRF) and CRF messenger ribonucleic acid. J. Clin. Endocrinol. Metab. 74: 1427-1431.
18. FABBRI, A., J.C. TINAJERO & M.L. DUFAU. 1990. Corticotropin-releasing factor is produced by rat Leydig cells and has a major local antireproductive role in the testis. Endocrinology 127: 1541-1543.
19. ULISSE, S., A. FABBRI & M.L. DUFAU. 1989. Corticotropin-releasing factor receptors and actions in rat Leydig cells. J. Biol. Chem. 264: 2156-2163.
20. MASTORAKOS, G. et al. 1993. Immunoreative corticotropin releasing hormone (CRH) and its binding sites in the rat ovary. J. Clin. Invest. 92: 961-968.
21. MASTORAKOS, G. et al. 1994. Presence of immunoreactive corticotropin releasing hormone (CRH) in normal and polycystic human ovaries. J. Clin. Endocrinol. Metab. 79: 1191-1197.
22. LINTON, E.A. et al. 1988. A specific carrier substance for human corticotrophin releasing factor in late gestational maternal plasma which could mask the ACTH-releasing activity. Clin. Endocrinol. (Oxf.) 28: 315-324.
23. CHEN, R. et al. 1993. Expression cloning of a human corticotropin- releasing-factor receptor. Proc. Natl. Acad. Sci. USA 90: 8967-8971.
24. VAMVAKOPOULOS, N.C. & T.O. SIOUTOPOULOU. 1994. Human corticotropin-releasing hormone receptor gene (CRHR) is located on the long arm of chromosome 17 (17q12-qter). Chromosome Res. 2: 471-473.
25. SLOMINSKI, A. et al. 2001. Cutaneous expression of corticotropin- releasing hormone (CRH), urocortin, and CRH receptors. FASEB J. 15: 1678-1693.
26. WATANABE, T. & D.N. ORTH. 1987. Detailed kinetic analysis of adrenocorticotropin secretion by dispersed rat anterior pituitary cells in a microperifusion system: effects of ovine corticotropin-releasing factor and arginine vasopressin. Endocrinology 121: 1133-1145.
27. WYNN, P.C. et al. 1985. Regulation of corticotropin-releasing factor (CRF) receptors in the rat pituitary gland: effect of adrenalectomy on CRF receptors and corticotropin responses. Endocrinology 116: 1653-1659.
28. HAUGER, R.L. & G. AGUILERA. 1993. Regulation of pituitary corticotropin releasing hormone (CRH) receptors by CRH: interaction with vasopressin. Endocrinology 133: 1708-1714.
29. MASTORAKOS, G., C. BAMBERGER & G. CHROUSOS. 1999. Neuroendocrine regulation of the immune process. In Cytokines, Stress and Immunity. N.P. Plotnikoff et al., Eds.: 17-37. CRC Press. Boca Raton, FL.
30. DECHERNEY, G.S. et al. 1985. Diurnal variation in the response of plasma adrenocorticotropin and cortisol to intravenous ovine corticotropin-releasing hormone. J. Clin. Endocrinol. Metab. 61: 273-279.
31. ARON, D.C. et al. 2001. Glucocorticoids and adrenal androgens. In Basic and Clinical Endocrinology. F.S. Greenspan and D. G. Gardner, Eds.: 334-376. Prentice Hall. Hartford, CT.
32. CONAGLEN, J.V. et al. 1984. The effect of ovine corticotropin-releasing factor on catecholamine, vasopressin, and aldosterone secretion in normal man. J. Clin. Endocrinol. Metab. 58: 463-466.
33. PAVLOV, E.P. et al. 1986. Responses of plasma adrenocorticotropin, cortisol, and dehydroepiandrosterone to ovine corticotropin-releasing hormone in healthy aging men. J. Clin. Endocrinol. Metab. 62: 767-772.
34. CHROUSOS, G.P. et al. 1998. Interactions between the hypothalamic- pituitary-adrenal axis and the female reproductive system: clinical implications. Ann. Intern. Med. 129: 229-240.
35. RABIN, D. et al. 1988. Stress and reproduction: interactions between the stress and reproductive axis. In Mechanisms of Physical and Emotional Stress. G.P. Chrousos, D.L. Loriaux, and P.W. Gold, Eds.: 377-387. Plenum Press. New York.
36. RIVIER, C. et al. 1986. Stress-induced inhibition of reproductive function: role of endogenous corticotropin releasing factor. Science 231: 607-609.
37. VAMVAKOPOULOS, N.C. et al. 1993. Evidence of direct estrogen regulation of human corticotropin releasing hormone gene expression: potential implications for the sexual dimorphism of the stress response and immune/inflammatory reaction. J. Clin. Invest. 92: 1896-1902.
38. MAGIAKOU, M.A. et al. 1997. The hypothalamic-pituitary-adrenal axis and the female reproductive system. Ann. N.Y. Acad. Sci. 816: 42-56.
39. MASTORAKOS, G. et al. 1994. Presence of immunoreactive corticotropin releasing hormone in normal and polycystic human ovaries. J. Clin. Endocrinol. Metab. 79: 1191-1197.
40. GHIZZONI, L. et al. 1997. Corticotropin-releasing hormone (CRH) inhibits steroid biosynthesis by cultured human granulose-lutein cells in a CRH and interleukin-1 receptor-mediated fashion. J. Clin. Endocrinol. Metab. 138: 4806-4811.
41. STEVENS, Y & J.R.G. CHALLIS. 1998. Corticotropin-releasing hormone receptor subtype 1 (CRH-R1) is significantly upregulated at the time of labor in the human myometrium. J. Clin. Endocrinol. Metab. 83: 4107-4115.
42. RODRIGUEZ-LINARES, B. et al. 1998. Expression of corticotropin-releasing hormone receptor mRNA and protein in the human myometrium. J. Endocrinol. 156: 15-21.
43. GRAMMATOPOULOS, D. et al. 1996. The biological activity of the corticotropin-releasing hormone receptor-adenylate cyclase complex in human myometrium is reduced at the end of pregnancy. J. Clin. Endocrinol. Metab. 81: 745-751.
44. ZOUMAKIS, E. et al. 1997. Endometrial corticotropin-releasing hormone. Its potential autocrine and paracrine actions. Ann. N.Y Acad. Sci. 828: 84-94.
45. CLIFTON, V.L. et al. 1998. Corticotropin-releasing hormone and proopiomelanocortin-derived peptides are present in human myometrium. J. Clin. Endocrinol. Metab. 83: 3716-3721.
46. MAKRIGIANNAKIS, A. et al. 2001. Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nat. Immunol. 2: 1018-1024.
47. NOLTEN, W.E. et al. 1980. Diurnal patterns and regulation of cortisol secretion in pregnancy. J. Clin. Endocrinol. Metab. 51: 466-472.
48. GOLAND, R.S. et al. 1998. Biologically active corticotropin-releasing hormone in maternal and fetal plasma during pregnancy. Am. J. Obstet. Gynecol. 159: 884-890.
49. GOLAND, R.S. et al. 1986. High levels of corticotropin releasing hormone immunoreactivity in maternal and fetal plasma during pregnancy. J. Clin. Endocrinol. Metab. 63: 1199-1203.
50. RILEY, S.C. et al. 1991. Corticotropin-releasing hormone production by the placenta and fetal membranes. Placenta 12: 105-119.
51. SASAH, A. et al. 1987. Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor, and delivery. J. Clin. Endocrinol. Metab. 64: 224-229.
52. JESKE, W. et al. 1990. Enhancement of plasma corticotropin-releasing hormone in pregnancy-induced hypertension. Acta Endocrinol. (Copenh.) 122: 711-714.
53. Ni, X. et al. 2002. Estrogen represses whereas the estrogen-antagonist ICI 182780 stimulates placental CRH gene expression. J. Clin. Endocrinol. Metab. 87: 3774-3778.
54. SAEED, B.O. et al. 1997. Characterization of corticotropin-releasing hormone binding sites in the human placenta. J. Recept. Signal Transduct. Res. 17: 647-666.
55. KARTERIS, E. et al. 1998. The human placenta and fetal membranes express the corticotropin-releasing hormone receptor 1alpha (CRH-1alpha) and the CRH-C variant receptor. J. Clin. Endocrinol. Metab. 83: 1376-1379.
56. WARREN, W.B. et al. 1990. Elevated maternal plasma corticotropin releasing hormone levels in twin gestation. J. Perinat. Med. 18: 39-44.
57. SUDA, T. et al. 1991. Presence of CRH-binding protein in amniotic fluid and in umbilical cord plasma. Acta Endocrinol. (Copenh.) 125: 165-169.
58. ORTH, D.N. et al. 1987. Specific high-affinity binding protein for human corticotropin-releasing hormone in normal human plasma. Biochem. Biophys. Res. Commun. 143: 411-417.
59. SUDA, T. et al. 1988. Characterization of corticotropin-releasing hormone binding protein in human plasma by chemical cross-linking and its binding during pregnancy. J. Clin. Endocrinol. Metab. 67: 1278-1283.
60. LINTON, E.A. et al. 1993. Corticotropin-releasing hormone-binding protein (CRH-BP): plasma levels decrease during the third trimester of normal human pregnancy. J. Clin. Endocrinol. Metab. 76: 260-262.
61. CLIFTON, V.L. et al. 1994. Corticotropin-releasing-hormone-induced vasodilation in the human fetal placental circulation. J. Clin. Endocrinol. Metab. 79: 666-669.
62. MAGIAKOU, M. A. et al. 1996. Placental CRH secretion and the maternal hypothalamic-pituitary-adrenal axis in human pregnancy. Clin. Endocrinol. (Oxf.) 44: 419-428.
63. WADHWA, P.D. et al. 1997. Placental CRH modulates maternal pituitary-adrenal function in normal pregnancy. Ann. N.Y. Acad. Sci. 814: 276-281.
64. JESKE, WP. et al. 1989. Plasma GHRH, CRH, ACTH, beta-endorphin, human placental lactogen, GH and cortisol concentrations at the third trimester of pregnancy. Acta Endocrinol. (Copenh.) 120: 785-789.
65. SCHULTE, H.M. et al. 1990. The corticotropin-releasing hormone test in late pregnancy: lack of adreenocorticotropin and cortisol response. Clin. Endocrinol. (Oxf.) 33: 99-106.
66. TAYLOR, R.N. et al. 2001. The endocrinology of pregnancy. In Basic and Clinical Endocrinology. F.S. Greenspan and D.G. Baxter, Eds.: 575-602. Prentice Hall. Hartford, CT.
67. LAATIKANEN, T. et al. 1987. Immunoreactive corticotropin releasing factor and corticotropin in plasma during pregnancy, labor and puerperium. Neuropeptides 10: 343-353.
68. TUIMALA, R. et al. 1976. ACTH levels in amniotic fluid during pregnancy. Br. J. Obstet. Gynaecol. 83: 853-856.
69. ROSENTHAL, H.E. et al. 1969. Transcortin: a cortocosteroid-binding protein of plasma. Cortisol and progesterone interplay and unbound levels of these steroids in pregnancy. J. Clin. Endocrinol. Metab. 29: 352-367.
70. ABOU-SAMRA, A.B. et al. 1984. Increased plasma concentrations of N-terminal beta-lipoprotein and unbound cortisol during pregnancy. Clin. Endocrinol. (Oxf.) 20: 221-228.
71. LINDHOLM, J. et al. 1973. Plasma and urinary cortisol in pregnancy and during estrogen-gestagen treatment. Scand. J. Clin. Lab. Invest. 31: 119-122.
72. OHANA, E. et al. 1996. Maternal plasma and amniotic fluid cortisol and progesterone concentrations between women with and without term labor. A comparison. J. Reprod. Med. 41: 80-86.
73. WINTOUR, E.M. et al. 1986. Effect of long-term infusion of CRF in the immature ovine fetus. J. Endocrinol. 111: 469-475.
74. GIUSSANI, D.A. et al. 1998. Changes in fetal plasma corticotropin- releasing hormone during androstenedione-induced labor in the rhesus monkey: lack of an effect on the fetal hypothalamo-pituitary-adrenal axis. Endocrinology 139: 2803-2810.
75. MAJZOUB, J.A. & K.P. KARALIS. 1999. Placental corticotropin-releasing hormone: function and regulation. Am. J. Obstet. Gynecol. 180(Suppl.): 242-246.
76. KOREBRITS, C. et al. 1998. Maternal corticotropin-releasing hormone is increased with impending preterm birth. J. Clin. Endocrinol. Metab. 83: 1585-1591.
77. BERGANT, A.M. et al. 1998. Childbirth as a biological model for stress? Associations with endocrine and obstetric factors. Gynecol. Obstet. Invest. 45: 181-185.
78. FLORIDO, J. et al. 1997. Plasma concentrations of beta-endorphin and adrenocorticotropic hormone in women with and without childbirth preparation. Eur. J. Obstet. Gynecol. Reprod. Biol. 73: 121-125.
79. MCLEAN, M. et al. 1995. A placental clock controlling the length of human pregnancy. Nat. Med. 1: 460-463.
80. CHALLIS, J.R.G. et al. 2002. Endocrine and paracrine regulation of birth at term and preterm. Endocr. Rev. 21: 514-550.
81. KARALIS, K., G. GOODWIN & J.A. MAJZOUB. 1996. Cortisol blockade of progesterone: a possible molecular mechanism involved in the initiation of human labor. Nat. Med. 2: 556-560.
82. PATEL, F.A. & J.R.G. CHALLIS. 2002. Cortisol/progesterone antagonism in regulation of 15-hydroxysteroid dehydrogenase activity and mRNA levels in human chorion and placental trophoblast cells at term. J. Clin. Endocrinol. Metab. 87: 700-708.
83. ROMERO, R. et al. 1988. Evidence for a local change in the progesterone/estrogen ratio in human parturition. Am. J. Obstet. Gynecol. 159: 657-660.
84. GOMEZ, M.T. et al. 1993. The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic-pituitary- adrenal axis in patients with Cushing syndrome. J. Clin. Endocrinol. Metab. 77: 173-177.
85. MAGIAKOU, M.A. et al. 1996. Hypothalamic CRH suppression during the postpartum period: implications for the increase of psychiatric manifestations in this period. J. Clin. Endocrinol. Metab. 81: 1912-1917.
86. ALTEMUS, M. et al. 1995. Suppression of hypothalamic-pituitary-adrenal axis responses to stress in lacating women. J. Clin. Endocrinol. Metab. 80: 2954-2959.
87. VAMVAKOPOULOS, N.C. et al. 1993. Structural organization of the 5′ flanking region of the human corticotropin releasing hormone gene. DNA Seq. 4: 197-206.
88. SCLEIN, PA. et al. 1974. The role of prolactin in the depressed or "buffered" adrenocorticostroid response in the rat. J. Endocrinol. 62: 93-99.
89. ENDROCZI, E. et al. 1972. Pituitary adrenal responses of lactating rats and the effect of prolactin administration. Hormones 3: 267.
90. HEINRICHS, M. et al. 2001. Effects of suckling on hypothalamic-pituitary- adrenal axis responses to psychosocial stress in postpartum lactating women. J. Clin. Endocrinol. Metab. 86: 4798-4804.
91. FLEMING, A.S. et al. 1997. Cortisol, hedonics, and maternal responsiveness in human mothers. Horm. Behav. 32: 85-98.
92. SANDMAN, C.A. et al. 1997. Maternal stress, HPA activity, and fetal/infant outcome. Ann. N.Y. Acad. Sci. 814: 266-275.
93. HEDEGAARD, M. et al. 1993. Psychological distress in pregnancy and preterm delivery. Br. Med. J. 307: 234-239.
94. KURKI, T. et al. 1991. Maternal plasma corticotropin-releasing hormone - elevated in preterm labour but unaffected by indomethacin or nylidrin. Br. J. Obstet. Gynaecol. 98: 685-691.
95. KEELAN, J.A. et al. 1997. The molecular mechanisms of term and preterm labor: recent progress and clinical implications. Clin. Obstet. Gynecol. 40: 460-478.
96. WALLACE, C. et al. 1996. Pregnancy-induced Cushing's syndrome in multiple pregnancies. J. Clin. Endocrinol. Metab. 81: 15-21.
97. FLORES, D.L. & V.C. HENDRICK. 2002. Etiology and treatment of postpartum depression. Curr. Psychiatry Rep. 4: 461-466.
98. COPPER, P.J. et al. 1998. Postnatal depression. Br. Med. J. 316: 1884-1886.
99. O'HARA, M.W. 1997. The nature of postpartum depressive disorders. In Postpartum Depression and Child Development. L. Murray and P.J. Cooper, Eds.: 3-37. Guilford, New York.
100. AVGERINOS, RC. et al. 1987. The corticotropin releasing hormone test in the postoperative evaluation of patients with Cushing's syndrome. J. Clin. Endocrinol. Metab. 65: 906-913.
101. GRIGORIADIS, S. & S.H. KENNEDY. 2002. Role of estrogen in the treatment of depression. Am. J. Ther. 9: 503-509.
102. GREGOIRE, A.J. et al. 1996. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 347: 930-933.
103. WILDER, R.L. 1998. Hormones, pregnancy, and autoimmune diseases. Ann. N.Y. Acad. Sci. 840: 45-50.
104. OLSEN, N.J. & W.J. KOVACS. 2002. Hormones, pregnancy, and rheumatoid arthritis. J. Gend. Specif. Med. 5: 28-37.
105. ELENKOV, I.J. et al. 1997. Does differential neuroendocrine control of cytokine production govern the expression of autoimmune diseases in pregnancy and the postpartum period? Mol. Med. Today 3: 379-383.
106. LANSINK, M. et al 1993. The onset of rheumatoid arthritis in relation to pregnancy and childbirth. Clin. Exp. Rheumatol. 11: 171-174.
107. MULLER, A.F., H.A. DREXHAGE & A. BERGHOUT. 2001. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr. Rev. 22: 605-630.
108. CHROUSOS, G.P. 1995. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332: 1309-1315.
109. STRATAKIS, C.A. et al. 1997. Thyroid function in children with Cushing's disease before and after transsphenoidal surgery. J. Pediatr. 131: 905-909.
110. GITAU, R. et al. 2001. Fetal hypothalamic-pituitary-adrenal stress responses to invasive procedures are independent of maternal responses. J. Clin. Endocrinol. Metab. 86: 104-109.
111. ROSE, J.C. et al. 1998. Development of the corticotropin-releasing factor adrenocorticotropic hormone/-endorphin system in the mammalian fetus. In Fetal and Neonatal Physiology, 2nd ed. R.A. Polin and W.W. Fox, Eds.: 2431-2442. Saunders. Philadelphia, PA.
112. MESIANO, S. & R.B. JAFFE. 1997. Developmental and functional biology of the primate fetal adrenal cortex. Endocr. Rev. 18: 378-403.
113. PEPE, G.J. & E.D. ALBRECHT. 1995. Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr. Rev. 16: 608-648.
114. HANNA, C.E. et al. 1993. Hypothalamic pituitary adrenal function in the extremely low birth weight infant. J. Clin. Endocrinol. Metab. 76: 384-387.
115. NG, P.C. et al. 1997. The pituitary-adrenal responses to exogenous human corticotropin-releasing hormone in preterm, very low birth weight infants. J. Clin. Endocrinol. Metab. 82: 797-799.
116. HELBOCK, H.J., R.M. INSOFT & F.A. CONTE. 1993. Glucocorticoid- responsive hypotension in extremely low birth weight newborns. Pediatrics 92: 715-717.
117. HINGRE, R. V. et al. 1994. Adrenal steroidogenesis in very low birth weight preterm infants. J. Clin. Endocrinol. Metab. 78: 266-270.
118. LEE, M.M. et al. 1989. Serum adrenal steroid concentrations in premature infants. J. Clin. Endocrinol. Metab. 69: 1133-1136.
119. KORTE, C. et al. 1996. Adrenocortical function in the very low birth weight infant: improved testing sensitivity and association with neonatal outcome. J. Pediatr. 128: 257-263.
120. NG, P.C. et al. 1997. Pituitary-adrenal response in preteral very low birth weight infants after treatment with antenatal corticosteroids. J. Clin. Endocrinol. Metab. 82: 3548-3552.
121. NG, P.C. et al. 1989. Adrenal response in very low birthweight babies after dexamethasone treatment for bronchopulmonary dysplasia. Arch. Dis. Child. 64: 1721-1726.
122. NG, PC. et al. 1997. Pituitary-adrenal suppression and recovery in preteral very low birth weight infants after dexamethasone treatment for bronchopulmonary dysplasia. J. Clin. Endocrinol. Metab. 82: 2429-2432.
123. FORD, L.R. et al. 1997. Suppression and recovery of the neonatal hypothalamic-pituitary-adrenal axis after prolonged dexamethasone therapy. J. Pediatr. 131: 722-726.
124. ALKALAY, A.L. et al. 1990. Hypothalamic-pituitary-adrenal axis function in very low birth weight infants treated with dexamethasone. Pediatrics 86: 204-210.
125. CLARK, P.M. 1998. Programming of the hypothalamo-pituitary-adrenal axis and the fetal origins of adult disease hypothesis. Eur. J. Pediatr. 157: S7-S10.
126. SCHULZ, D.W. et al. 1996. CP-I54,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc. Natl. Acad. Sci. USA 93: 10477-10482.
127. TSIGOS, C. & G.P. CHROUSOS. 2002. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J. Psychosom. Res. 53: 865-871.